9 Best Things To Spend Your HSA Funds on in 2025
Here are some of the best things you can spend your HSA funds on in 2025.
Discover Next:
Read More:
Therapy and Mental Health Services
Generally, therapy or mental health services can be considered a qualified medical expense if it's deemed medically necessary by a licensed healthcare professional. If eligible, you can use your HSA funds to pay for sessions with psychologists, licensed clinical social workers and other qualified mental health providers. Online therapy platforms could also be eligible as long as they're run by licensed professionals.
Check Out:
Menstrual Products
Pads, tampons, panty liners, menstrual cups and period underwear are subject to the pink tax and can get pretty expensive. Thankfully, with the passage of the CARES Act in 2020, period products are now HSA-eligible. Because your HSA contributions are tax-free, you can at least avoid being double taxed on the expense by using your HSA funds to pay for these products.
Sunscreen (SPF 15 or Higher)
Sunscreen is also HSA-eligible as long as it's SPF 15 or higher and labeled as broad spectrum. This means it protects against both UVA and UVB rays. Note that your benefits administrator may request itemized receipts to verify your expenses. So if you aren't sure whether a sunscreen product is eligible for reimbursement or not, reach out to your HSA administrator or tax advisor to confirm before buying.
First-Aid Supplies
You can also use your HSA funds to build or restock your first-aid kit, including things like bandages, antiseptic wipes, antibiotic ointments, gauze and thermometers. Some specialized items in advanced kits might not be covered, so check with your HSA guidelines.
Glasses, Contacts and LASIK Surgery
Another area you can use your HSA funds on is vision care, including eye exams, prescription eyeglasses, contact lenses and prescription sunglasses. LASIK surgery is also an eligible expense.
Acupuncture and Chiropractic Care
Alternative treatments like acupuncture and chiropractic care may be HSA-approved if they're required for the treatment, diagnosis or prevention of a disease or illness. Some benefits administrators may also require a letter of medical necessity (LMN) from the healthcare provider to show how the alternative treatment can alleviate the issue.
Dental Care
You can use your HSA to pay for cleanings, x-rays, fillings, crowns and other dental work. This includes both preventive and restorative services. Orthodontic treatments, like braces or Invisalign, are also eligible if they're medically necessary.
Pregnancy and Fertility Items
Prenatal vitamins, pregnancy tests, ovulation kits and breast pumps all qualify. You can also use your HSA for childbirth classes, lactation support and doula services in some cases. If you're going through IVF or fertility treatments, check to see which parts of the process are eligible.
Over-the-Counter Medications
You no longer have to wait for a doctor's prescription to use HSA funds for most over-the-counter drugs. This includes allergy medicine, cold and flu remedies, pain relievers like ibuprofen or acetaminophen and heartburn medications. Just make sure you save your receipts in case you need to verify your purchases later.
What You Can't Use Your HSA For
Generally, you can't use your HSA to pay for things that don't meaningfully promote the proper function of the body or prevent/treat illness or disease. You also can't use HSA funds to pay premiums.
If you take money out of your HSA for something other than qualified medical expenses before you turn 65, you'll have to pay income tax plus a 20% penalty. But once you turn 65, you can use the money in your HSA for anything you want.
Take Advantage of Your HSA
Your HSA can help you save money on the products and services you already use to take care of your health. Before making a purchase, it's always a good idea to double-check if the item qualifies. But in general, if it's tied to your health or wellness, there's a good chance it's HSA-eligible.
More From GOBankingRates
3 Luxury SUVs That Will Have Massive Price Drops in Summer 2025
10 Cars That Outlast the Average Vehicle
Mark Cuban Says Trump's Executive Order To Lower Medication Costs Has a 'Real Shot' -- Here's Why
This article originally appeared on GOBankingRates.com: 9 Best Things To Spend Your HSA Funds on in 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
6 minutes ago
- Medscape
Wives of Farm Pesticide Applicators at Risk for Incident RA
TOPLINE: Among female spouses of licensed pesticide applicators, the personal use of organochlorine insecticides was associated with an increased risk for rheumatoid arthritis (RA). Among women who did not use specific pesticides personally, the applicator's use of specific pesticides was associated with incident RA. METHODOLOGY: Researchers investigated whether the use of pesticides influenced the risk for RA in a cohort of female spouses of licensed pesticide applicators from North Carolina and Iowa (1993-1997). They included 32,126 female spouses and collected data on their direct pesticide use or indirect exposure, regular farming tasks, and other demographic and lifestyle factors. Cases of incident RA were identified using follow-up questionnaires, medical records, medication use, and claims data. The analysis included 410 participants with probable RA (median age, 51 years) and 21,850 without RA (median age, 45 years), with a median survey follow-up duration of 10 and 19 years and a median of 0.5 and 8 fee-for-service years among those with Medicare data, respectively. A total of 32 specific pesticides were included in the final analysis, and their associations with RA were estimated. TAKEAWAY: Almost half of the participants never used agricultural pesticides. Most reported using them for 20 days or less each year (adjusted odds ratio [aOR], 1.26; 95% CI, 1.01-1.57 vs never use) and for 20 years or less, with no higher odds being observed among those who used them more. The personal use of organochlorine insecticides was associated with a higher likelihood for incident RA (aOR, 1.54; 95% CI, 1.14-2.07), especially with the use of dichlorodiphenyltrichloroethane (aOR, 1.89; 95% CI, 1.30-2.75) and lindane (aOR, 1.97; 95% CI, 1.12-3.47); among the organophosphate insecticides, coumaphos use showed a stronger association (aOR, 2.32; 95% CI, 1.29-4.19). Among spouses who never used specific pesticides themselves, the applicator's use of metribuzin was associated with increased odds of RA (aOR, 1.66; 95% CI, 1.10-2.52). The use of any fungicide was associated with increased odds of RA (aOR, 1.72; 95% CI, 1.24-2.38). Several farming activities, such as cleaning with solvents, driving a gas tractor, grinding feed, painting, applying chemical fertilizer, and planting, were significantly associated with RA. IN PRACTICE: '[The study] findings provide robust evidence that some insecticides may contribute to risk of developing RA in women. While insecticides are an important tool in controlling threats to crops and human health, our results provide evidence of potential risks,' the authors wrote. SOURCE: This study was led by Christine G. Parks, PhD, Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina. It was published online on July 16, 2025, in Arthritis & Rheumatology. LIMITATIONS: Some cases of RA may have been missed by the algorithm, and clinical data and details such as serology of RA were missing. The study had insufficient statistical power to examine differences by risk factors linked to seropositive and seronegative RA. The exposure to pesticides was self-reported, and the frequency or duration of pesticide use in spouses was lacking. DISCLOSURES: This study received support in part from the intramural research program of the National Institutes of Health, the National Institute of Environmental Health Sciences, and the National Cancer Institute. The authors reported having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
CNN
8 minutes ago
- CNN
‘Ozempic face' may be driving a cosmetic surgery boom
About two years ago, celebrity cosmetic dermatologist Dr. Paul Jarrod Frank noticed a new type of patient arriving at his New York practice. Amid an explosion in the number of Americans losing weight with drugs like Ozempic, he saw a 'dramatic spike' in clients experiencing unwelcome side effects. 'Although they felt much better losing weight, in some ways they felt they looked older,' he said via a voice note. 'And this was due to the loss of volume in their face.' Frank started using the term 'Ozempic face' — a label he believes he coined — to describe the phenomenon. It has since become a social media byword for the sagging skin and hollowed-out appearance that can accompany the use of GLP-1 medications like semaglutide (the active ingredient in branded drugs such as Ozempic and Wegovy). 'Usually, with people from their mid-40s and above, once you start losing 10-plus pounds, you can get this kind of deflated look,' said Frank, who is the founder of aesthetic health care brand PFRANKMD and the author of 'The Pro-Aging Playbook.' 'Certainly, people losing 20 or 30-plus pounds are going to have this problem.' 'You can only refill a deflated balloon so much, and often surgical intervention is necessary.' Dr. Paul Jarrod Frank Semaglutide works by stimulating the pancreas to trigger insulin production, curbing users' appetite and contributing to feelings of fullness. Although the US Food and Drug Administration approved Ozempic to treat type 2 diabetes, doctors now commonly prescribe it off-label for weight management. About 1 in 8 adults in the US has used a GLP-1 drug, and of those, around 2 in 5 did so solely to lose weight, according to health policy non-profit KFF in 2024. Today, more than 20% of Frank's patients are using GLP-1s as part of what he called their 'longevity regimen.' The treatments sought after their weight loss include injectable dermal fillers to help restore facial volume, facelifts and fat transfers. 'You can only refill a deflated balloon so much, and often surgical intervention is necessary,' he said. But for many patients, he added, 'just upping the dosage of their volume replacement is more than enough. 'Someone who may have used one syringe of filler in the past is now using two or three.' The American Society of Plastic Surgeons (ASPS), which publishes an annual report on surgery trends, recently found that 2 in 5 of its members' GLP-1 patients were considering undergoing cosmetic surgery — and 1 in 5 already had. Among the patients opting for a facelift was Kimberly Bongiorno, a local government land use administrator from Mount Arlington, New Jersey. Having lost weight after gastric sleeve surgery in 2019, she regained 40 pounds during the Covid-19 pandemic and was prescribed Wegovy last year. Despite describing the drug's impact as 'almost a miracle' — taking her weight from 170 to 125 pounds — the 55-year-old faced new concerns over her appearance. 'Everything just kind of hung and was very loose,' she said over Zoom, recalling seeing her face in a photo shared by a friend. 'I no longer felt like I had cheeks, and I had a lot of loose skin under my neck. 'It looked like I had melted. It was horrifying,' she added. 'It was so disheartening to see how my face looked and how it had changed, I thought I looked a lot older than I am.' After consulting plastic surgeon Dr. Anthony Berlet at his New Jersey office, Bongiorno underwent a deep plane facelift that lifted her skin and repositioned some of the deeper muscles and connective tissues. She also opted for a neck lift that refined and smoothed her neck contours while addressing excess skin left by her weight loss. 'Before I did this, I probably looked closer to 60, or maybe even older. And now I have people who I've recently met think I am in my 40s,' Bongiorno said, adding: 'People I haven't seen in a while say, 'You look so healthy and happy.' And that's nice to hear, because for a while, I didn't look healthy and certainly wasn't happy.' The number of facelifts performed in the US jumped 8% between 2022 and 2023, according to ASPS data. The use of hyaluronic acid fillers has meanwhile doubled from 2.6 million Americans in 2017 — the year Ozempic was first cleared for diabetes — to over 5.2 million in 2023. The organization could not attribute these upticks exclusively to GLP-1 use, but its former president, Dr. Steven Williams, said the medications have had 'a global effect on aesthetic surgery.' 'Now we have a brand-new tool that actually has efficacy for so many patients,' said Williams, a board-certified plastic surgeon and founder of California's Tri Valley Plastic Surgery, over Zoom. He noted that GLP-1s come 'without substantial drawbacks' when compared with invasive procedures like gastric bypass surgery. 'We can now have an honest conversation with patients about a nonsurgical tool that's effective in weight loss,' he added. 'And as part of that conversation, there's an obligation to say, 'Look, this is really going to work, so you have to be prepared for what looking 20 or 50 pounds slimmer is going to be.'' The term 'Ozempic face' may speak to our times, but its symptoms — caused by a decrease in the subcutaneous fat that makes our faces plump — are nothing new. Cosmetic surgeons have long been treating the side effects of significant weight loss. In fact, one popular brand of dermal filler, Sculptra, was originally developed in the 1990s for HIV patients. As an adult, 'your body actually doesn't make more fat cells,' Williams said. 'As we lose or gain weight, those fat cells aren't multiplying or decreasing; they're getting bigger or smaller. And so as we lose weight, those fat cells now have decreased volume, and there's just less fullness.' Age can determine how patients' faces react to weight loss. People in their 20s and 30s, for instance, are far less likely to experience the appearance of aging due to GLP-1 use, Frank said. 'Because they have good skin elasticity, the skin rebounds much better,' he said. Patients aged 20 to 39 accounted for 14% of hyaluronic acid filler use in the US and just 2% of facelift procedures last year, according to the ASPS. But both figures are on the rise. Gabriela Vasquez, 29, is among the younger patients using GLP-1 to undergo cosmetic procedures after rapid weight loss. An employee of one of Williams' Tri Valley Plastic Surgery clinics, she has dropped around 50 pounds since starting Ozempic in November. Although Vasquez is still working toward her target weight, she sought preventative Botox injections (more visible lines and wrinkles are, along with thinning lips, among the other side effects of GLP-1 use). She has also recently undergone microneedling, a procedure used to stimulate collagen production. 'One of my concerns was my jowls, because I felt I saw them when I was a little heavier,' she said over Zoom from the Bay Area. 'I think the microneedling definitely helped. 'I never had a jaw line,' she added. 'And a couple weeks ago, someone took a picture of me, and I had one, and I was like, 'Well, that's new.'' Vasquez did not rule out further cosmetic procedures as she continues losing weight — and not only to her face and neck. 'I'm seeing little things in my body that I'm like, 'Whoa, that would be nice to take care of,'' she said, referencing the appearance of excess skin under her arms. 'I could see myself — later down the line, once I get to my goal weight — doing something to kind of tighten everything up.' Frank, the cosmetic dermatologist, noted that 'Ozempic face' may be accompanied by a phenomenon he dubbed 'Ozempic body,' adding: 'One of the other major side effects of weight loss, particularly when it's done at a rate of more than one to two pounds a week, is muscle loss. And we see this all over the body.' The ASPS similarly notes the emerging term 'Ozempic makeover,' a suite of procedures that might also include tummy tucks, breast lifts and arm, thigh and buttock lifts. For instance, Bongiorno, the New Jersey facelift patient, has also undergone several other procedures with Dr. Berlet, including arm and thigh lifts, to address her excess skin. She estimates that after her upcoming breast lift, fat grafting and lower eyelid surgery, she will have spent about $80,000 on cosmetic procedures. 'Skin is heavy and uncomfortable,' she said. 'This wasn't something I did to go out there and be a supermodel. It was just to be comfortable, so I could get clothes on and not feel like I was dragging around all this extra weight.' The long-term effect of GLP-1 medications on cosmetic medicine is yet to be fully understood. The assumption they might reduce demand for liposuction, for instance, has not come to bear: It remains the most common cosmetic surgical procedure in the US, growing in popularity by 1% last year, per ASPS data. What also remains to be seen is the effect that 'Ozempic rebound' — when patients regain weight after stopping the drugs — has on people who sought cosmetic procedures. A recent peer-reviewed study found that most people using the drugs for weight loss quit within a year. Data presented at this year's European Congress on Obesity meanwhile suggested that patients typically returned to their original weight within 10 months of stopping use, with University of Oxford researchers calling the findings a 'cautionary note' about using medication 'without a more comprehensive approach' to weight loss. For Williams, this further demonstrates why he and his plastic surgeon colleagues must take responsibility for their patients' 'entire journey,' not just their cosmetic procedures. 'We don't want these patients to be on these medications for a lifetime. We want it to be a temporary bridge to a healthier lifestyle,' he said, adding: 'It's our obligation to work harder with those patients, to talk about lifestyle changes, to get them plugged in to dietitians and to make sure that they're building muscle and exercising.'
Wall Street Journal
8 minutes ago
- Wall Street Journal
UnitedHealth Faces Long Road to Recovery
For years, UnitedHealth's UNH -7.46%decrease; red down pointing triangle stock was one of the surest bets in healthcare, backed by dependable double-digit earnings growth and a reputation for flawless execution. But the halo that once made it a Wall Street darling—worth over half a trillion dollars at its peak in late 2024—is gone. Whether it can be restored anytime soon is now an open question.
